AR026523A1 - Uso de compuestos paa el tratamiento transdermico de infecciones bacterianas - Google Patents

Uso de compuestos paa el tratamiento transdermico de infecciones bacterianas

Info

Publication number
AR026523A1
AR026523A1 ARP000106086A ARP000106086A AR026523A1 AR 026523 A1 AR026523 A1 AR 026523A1 AR P000106086 A ARP000106086 A AR P000106086A AR P000106086 A ARP000106086 A AR P000106086A AR 026523 A1 AR026523 A1 AR 026523A1
Authority
AR
Argentina
Prior art keywords
bacterial infections
compounds
transdermal treatment
treatment
transdermal
Prior art date
Application number
ARP000106086A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8239432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR026523(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR026523A1 publication Critical patent/AR026523A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de un compuesto de la formula (1) en donde los sustituyentes tienen los significados dados en la memoria descriptiva, para la fabricacion de unmedicamento para el tratamiento de infecciones bacterianas en seres humanos y animales. Además se descr iben composiciones transdérmicas para este tratamiento.
ARP000106086A 1999-11-22 2000-11-17 Uso de compuestos paa el tratamiento transdermico de infecciones bacterianas AR026523A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99123095 1999-11-22

Publications (1)

Publication Number Publication Date
AR026523A1 true AR026523A1 (es) 2003-02-12

Family

ID=8239432

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106086A AR026523A1 (es) 1999-11-22 2000-11-17 Uso de compuestos paa el tratamiento transdermico de infecciones bacterianas

Country Status (22)

Country Link
US (1) US6852756B1 (es)
EP (1) EP1231915B1 (es)
JP (1) JP3892298B2 (es)
KR (1) KR100529660B1 (es)
CN (1) CN100344281C (es)
AR (1) AR026523A1 (es)
AT (1) ATE289196T1 (es)
AU (1) AU764451B2 (es)
BR (1) BR0015722A (es)
CA (1) CA2386685C (es)
CO (1) CO5261531A1 (es)
DE (1) DE60018200T2 (es)
DK (1) DK1231915T3 (es)
ES (1) ES2237495T3 (es)
HK (1) HK1052643B (es)
MX (1) MXPA02005149A (es)
NZ (1) NZ518348A (es)
PT (1) PT1231915E (es)
RU (1) RU2264812C2 (es)
TW (1) TWI260220B (es)
WO (1) WO2001037828A1 (es)
ZA (1) ZA200203901B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2450728C (en) 2001-06-15 2011-04-26 Forty Eight Shelf (80) Limited Composition for the treatment of diseases which affect animals' hooves
CO5390081A1 (es) 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
ES2335284T3 (es) * 2003-09-03 2010-03-24 Glaxo Group Limited Nuevo procedimiento para preparar derivados de pleuromutilina.
GB0504314D0 (en) 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph
EP1808431A1 (en) * 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin derivatives and their use as pharmaceutical
CN102415989A (zh) * 2011-09-30 2012-04-18 上海恒丰强动物药业有限公司 盐酸沃尼妙林溶液剂及其制备方法
CN110225746A (zh) * 2016-11-09 2019-09-10 普罗维塔欧洲技术有限公司 用于治疗兽蹄感染的抗微生物制剂
GB201715122D0 (en) * 2017-09-19 2017-11-01 Omnipharm Dev Ltd Topical anti-infective formulation
KR102098289B1 (ko) * 2018-04-11 2020-04-07 경북대학교 산학협력단 발네물린을 유효성분으로 함유하는 골 질환 예방 또는 치료용 조성물
CN109431980A (zh) * 2018-12-27 2019-03-08 山东齐发药业有限公司 一种用于治疗动物皮肤细菌感染的羟啶妙林软膏剂及其制备方法
CN114366732B (zh) * 2022-02-23 2023-08-18 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 泰妙菌素在制备用于治疗银屑病的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT301752B (de) * 1969-07-21 1972-09-25 Biochemie Gmbh Verfahren zur Herstellung neuer Pleuromutilin-Derivate
DE2614841A1 (de) 1976-04-06 1977-10-20 Bayer Ag Neue pour-on-formulierungen von anthelmintika
EP0153277B1 (de) * 1984-02-17 1987-08-26 Sandoz Ag Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds
GB9807503D0 (en) * 1998-04-07 1998-06-10 Smithkline Beecham Plc Use

Also Published As

Publication number Publication date
CA2386685A1 (en) 2001-05-31
TWI260220B (en) 2006-08-21
CN100344281C (zh) 2007-10-24
AU764451B2 (en) 2003-08-21
NZ518348A (en) 2003-11-28
ZA200203901B (en) 2003-09-23
MXPA02005149A (es) 2002-11-07
RU2264812C2 (ru) 2005-11-27
EP1231915B1 (en) 2005-02-16
US6852756B1 (en) 2005-02-08
DE60018200T2 (de) 2006-01-12
RU2002116252A (ru) 2004-01-20
CN1391472A (zh) 2003-01-15
CO5261531A1 (es) 2003-03-31
ATE289196T1 (de) 2005-03-15
AU2836501A (en) 2001-06-04
EP1231915A1 (en) 2002-08-21
JP2003514856A (ja) 2003-04-22
PT1231915E (pt) 2005-07-29
KR100529660B1 (ko) 2005-11-21
KR20020053876A (ko) 2002-07-05
HK1052643B (zh) 2008-03-14
CA2386685C (en) 2009-05-19
DK1231915T3 (da) 2005-05-02
JP3892298B2 (ja) 2007-03-14
DE60018200D1 (de) 2005-03-24
ES2237495T3 (es) 2005-08-01
BR0015722A (pt) 2002-07-23
WO2001037828A1 (en) 2001-05-31
HK1052643A1 (en) 2003-09-26

Similar Documents

Publication Publication Date Title
AR029226A1 (es) Tioamidas, composiciones farmaceuticas y el uso de la misma para la fabricacion de compuestos medicinales
NO20052787L (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
EP1520472A3 (en) Herbicidal compositions comprising pyridoyl-1,3-cyclodiones
EA200500853A1 (ru) 2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака
AR047757A1 (es) Aminoacidos n,n-dihalogenados y derivados
AU2134402A (en) Antiviral agents
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
CY1109037T1 (el) Πιπεραζινες χρησιμες για θεραπεια πονου
CY1104996T1 (el) 9α-αζαλιδια εχοντα αντιβακτηριακην δρασιν
AR026523A1 (es) Uso de compuestos paa el tratamiento transdermico de infecciones bacterianas
PA8485601A1 (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
TR200001330T2 (tr) Oksazolidinon türevleri ve farmasötik terkipler
BG108498A (en) New derivatives of oxazolidinones as antibacterial agents
HRPK20030734B3 (en) A combination comprising combretastatin and anticancer agents
GEP20084437B (en) Novel lincomycin derivatives possessing antimicrobial activity
CY1119257T1 (el) Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα δεξτρομεθορφανης n-meθυλ-d-ασπαρτικων (nmda)
DK1197215T3 (da) Anthelmintiske sammensætninger
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
BR0312435A (pt) Compostos orgânicos
TW200602295A (en) Organic compounds
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
ATE368025T1 (de) Pleuromutilinderivate mit antimikrobieller wirkung
SE0104326D0 (sv) Therapeutic heterocycles
PT1059845E (pt) Composicao fungicida compreendendo uma benzoilfenilureia

Legal Events

Date Code Title Description
FB Suspension of granting procedure